Lymphatic metastasizing – viewed by pathologist

1. Kalluri R, Neilson EG. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420–1428.

2. Sobin LH, Gospodarowicz MK, Wittekind Ch. TNM Classification of Malignant Tumours, 7th Edition 2009, česká verze 2011.

3. Tomášek J, Vyzula R, Coufal O, Rejthar A, Kiss I. Mikrometastázy a volné nádorové buňky, metody detekce, význam vyšetření u kolorektálního karcinomu, Klinická onkologie 2002;15: 203–206.

4. Strnad P, Rob L, Škapa P, Stankušová H, Michalová K, et al. Prognóza žen s mikrometastázou karcinomu prsu v sentinelové uzlině. Prakt Gyn 2009;13:218–223.

5. Houvenaeghel G, Cohen M, Bannier M, Buttarelli M, Jauffret C, et al. Micrometastasis: biological entity and clinical impact? Bull Cancer 2013;100:351–356.

6. Van der Heiden-van der Loo M, Schaapveld M, Ho VK, Siesling S, Rutgers EJ, et al. Outcomes of a population-based series of early breast cancer patients with micrometastases and isolated tumour cells in axillary lymph nodes. Ann Oncol 2013; Jul 17. [Epub ahead of print]

7. Fujimura T, Tsukada T, Kinoshita J, Oyama K, Fushida, S, et al. Lymph node micrometastases in gastric cancer. Nihon Geka Gakkai Zasshi 2013;114:13–16.

8. Yamamoto H, Doki Y, Mori M. Lymph node micrometastases in colorectal cancer. Nihon Geka Gakkai Zasshi 2013;114:17–21.

9. Märkl B, Herbst C, Cacchi C, Schaller T, Krammer I, et al. Prognostic significance of histologically detected lymph node micrometastases of sizes between 0.2 and 2 mm in colorectal cancer. Int J Colorectal Dis 2013;28:977–983.

10. Osaki T, Yasumoto K. Clinical significance of micrometastases in the lymph nodes of patients with resectable lung cancer. Nihon Geka Gakkai Zasshi 2013;114:28–33.

11. Cserni G, Vinh-Hung V, Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol 2002;81:63–69.

12. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 2002;26:179–189.

13. Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a “sentinel node” in cancer 99 of the parotid. Cancer 1960;13: 77–78.

14. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456–466.

15. Krajsová I, Vítková I, Šuk J. Sentinelová uzlina – význam vyšetření u pacientů s melanomem. In: Dermatovenerologie, dětská dermatologie a korektivní dermatologie 2006/07 kolektiv autorů. Trendy v medicíně. Praha, Triton 2006:69–76.

16. Staník M, Čapák I, Macík D. Vyšetření sentinelové uzliny u karcinomu prostaty – mapování primární lymfatické drenáže a zhodnocení přínosu pro staging onemocnění. Ces Urol 2013;17: 42–50.

17. Redston M, Compton CC, Miedema BW, et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: Results of Cancer and Leukemia Group B trial 80001. J Clin Oncol 2006;24:878–883.

18. Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: Results of a multicenter study. Ann Surg 2004;240:624–630.

19. Roh JL, Koch WM. Role of sentinel lymph node biopsy in thyroid cancer. Expert Rev Anticancer Ther 2010;10:1429–1437.

20. Ji YB, Lee KJ, Park YS, Hong SM, Paik SS, at al. Clinical efficacy of sentinel lymph node biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma. Ann Surg Oncol 2012;19:1868–1873.

21. Weaver DL. Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale. Mod Pathol 2010;23:S26–32.

22. De Hullu JA, Hollema H, Piers DA. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000;18:2811–2816.

23. Terada KY, Schimizu DM, Wong JH. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 2000;76:40–44.

24. Madsen EV, van Dalen J, van Gorp, J, et al. Frozen section analysis of sentinel lymph nodes in patients with breast cancer does not impair the probability to detect lymph node metastases. Virchows Arch 2012;460:69–76.

25. Kitagawa Y, Ando N, Ozawa S, et al. Appropriate extent of lymphadenectomy in esophageal cancer. Nippon Geka Gakkai Zasshi 2001;102:477–483.

26. Miwa K. Optimal nodal dissection for early gastric cancer. Nippon Geka Gakkai Zasshi 2001;102:484–489.

27. Mukaiya M, Hirata, K, Satoh T, et al. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: Retrospective multinstitutional analysis in Japan. World J Surg 1998;22:248–252.

28. Henne-Bruns D, Vogel I, Luttges, J, et al. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg 2000;24:595–601.

29. Medina JE. Role of Elective Neck Dissection for the N0 Neck. In PENSAK, ML. Controversies in Otolaryngology. New York, Thieme 2001;476.

30. Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;26:884–889.

31. Delgado G, Bundy B, Zaino R, Sevin B, Creasman WT, et al. Prospective surgical-pathologic study of disease-free interval in patients with stage Ib squamous carcinoma of the cervix. Gynecologic Oncology 1990;38:352–357.

32. ASTEC study group: Kitchener H, Swart AM, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet 2009;373:125–136.